Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects
NCT00762801 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2016-10-26
Summary
RLIP76 (Ral binding protein1) is a 76 kDa splice variant protein encoded by the human gene (RALBP1, 18p11.22). It is a multifunctional modular protein found ubiquitously from Drosophila to humans, in cells ranging from red blood cells to endothelial cells of the brain. Its expression more predominant in breast, heart, liver and less so in colon and brain parenchyma.
Conditions
- Healthy
Sponsors & Collaborators
-
University of North Texas Health Science Center
lead OTHER
Principal Investigators
-
Sanjay Awasthi, MD · University of North Texas Health Science Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.
NCT01715623 ·Status: COMPLETED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.
NCT05703802 ·Status: COMPLETED
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Protective Immune Mechanisms in Alcoholic Hepatitis
NCT01918462 ·Status: COMPLETED
-
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
NCT00610597 ·Status: COMPLETED
-
Biomarker for Gilbert Disease (BioGilbert)
NCT02712138 ·Status: WITHDRAWN
-
Biomarker for Gaucher Disease: BioGaucher (BioGaucher)
NCT01331642 ·Status: WITHDRAWN
-
Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases
NCT02707211 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Prediction Value of PANX1 in Infection Post Liver Transplantation
NCT02693639 ·Status: UNKNOWN
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
NCT01644903 ·Status: RECRUITING
-
The Connection Between Liver Disease and Chitinase Proteins
NCT00852293 ·Status: UNKNOWN
-
Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)
NCT06623084 ·Status: NOT_YET_RECRUITING
-
MicroRNAs as Biomarkers in Patients With Chagas Disease
NCT01842880 ·Status: COMPLETED
-
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
NCT05865691 ·Status: RECRUITING
-
Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target
NCT06270524 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia
NCT05371392 ·Status: NOT_YET_RECRUITING
-
Biomarker for Farber Disease (BioFarber)
NCT02298634 ·Status: WITHDRAWN
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED
-
Hematological Disorders in Covid 19 Patients
NCT05182528 ·Status: UNKNOWN
-
Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
NCT00169871 ·Status: COMPLETED
-
Hepatitis C in Clinically Discordant Hemophilic Siblings
NCT00007371 ·Status: COMPLETED